Patient satisfaction with GP-led melanoma follow-up: A randomised controlled trial

British Journal of Cancer

Volumn 102, Issue 10, 2010, Pages 1447-1455

  Murchie, P ^a   Nicolson, M C ^b   Hannaford, P C ^a   Raja, E A ^c   Lee, A J ^a   Campbell, N C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Aftercare; Cutaneous melanoma; Follow up; Primary healthcare; Survivorship

Indexed keywords

ADULT; ANXIETY; ARTICLE; CANCER PATIENT; CUTANEOUS MELANOMA; DEPRESSION; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MELANOMA; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT INFORMATION; PATIENT SATISFACTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SHORT FORM 36;

DELIVERY OF HEALTH CARE; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HEALTH STATUS; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SATISFACTION; PRACTICE GUIDELINES AS TOPIC; SKIN NEOPLASMS;

EID: 77952180686     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605638     Document Type: Article

References (32)

1. Adewuyi-Dalton R, Ziebland S, Grunfeld E, Hall A (1998) Patients' views of routine hospital follow-up: a qualitative study of women with breast cancer in remission. Psycho-Oncology 7: 436-439
2. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52: 69-77
3. Cox K, Wilson E, Heath L, Collier J, Jones L, Johnston I (2006) Preferences for follow-up after treatment for lung cancer: assessing the nurse-led option. Cancer Nurs 29: 176-187
4. Dancey A, Rayatt S, Courthold J, Roberts J (2005) Views of UK melanoma patients on routine follow-up care. Br J Plast Surg 58: 245-250
5. Donner A, Klar N (2000) Design and Analysis of Cluster Randomization Trials in Health Research. Arnold: London, UK
6. Donner A, Klar N (1994) Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol 140(3): 279-289
7. Durkalski VL, Palesch YY, Lipsitz SR, Rust PF (2003) Analysis of clustered matched-pair data. Stat Med 22: 2417-2428
8. Fayers P, Machin D (2000) Quality of Life: Assessment, Analysis and Interpretation. Wiley UK: Chichester (UK)
9. Foy R, Duggan A, Delaney B, Wilson S, Lewin-van den Broek NTh, Lassen A, Vickers L, Myres P (2003) How evidence based are recruitment strategies to randomized controlled trials in primary care? Experience from seven studies. Fam Pract 20: 83-92
10. Francken AB, Bastiaannet E, Hoekstra HJ (2005) Follow-up in patients with localised primary cutaneous melanoma. Lancet Oncol 6: 608-621
11. Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, Cole D, Vessey M (1999) Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 49: 705-710
12. Grunfeld E, Levine AM, Julian JA, Coyle D, Szechtman B, Mirsky D, Shailendara V, Dent S, Sawka C, Pritchard KI, Ginsburg D, Wood M, Whelan T (2006) Randomised trial of long term follow-up for early-stage breast cancer. J Clin Oncol 24: 848-855
13. Grunfeld E, Mant D, Vessey MP, Fitzpatrick R (1995) Specialist and general practice views on routine follow-up of breast cancer patients in general practice. Fam Pract 12: 60-65
14. Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, Fitzpatrick R, Vessey M (1996) Routine follow-up of breast cancer in primary care: randomised trial. Br Med J 313: 665-669
15. Howells RE, Bradley E, Pitts M, Calvert E, Redman CW (1999) Audit of the views of gynaecological cancer patients regarding follow-up. J Obstet Gynaecol 19: 167-168
16. Lyons RA, Filed H, Littlepage BNC (1995) Measuring health status with the SF-36: the need for regional norms. J Public Health Med 17: 46-50
17. Martinez JC, Otley CC (2001) The management of melanoma and non-melanoma skin cancer: a review for the primary care physician. Mayo Clin Proc 76: 1253-1265
18. Martini L, Brandini P, Chiarugi C, Reali UM (1994) First recurrence analysis of 840 cutaneous malignant melanomas: a proposal for a follow-up schedule. Tumori 80: 188-197
19. McCarthy WH, Shaw HM, Thompson JF, Milton JW (1988) Time and frequency of recurrence of cutaneous stage I malignant melanoma with guidelines for follow-up. Surg Gynecol Obstet 166: 497-502
20. Meyers MO, Yeh JJ, Frank J, Long P, Allison MD, Amos KD, Ollila DW (2009) Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging. Ann Surg Oncol 16: 941-947
21. Moses SH, Olaitan A, Murcdoch JB (2004) A pilot randomised controlled study of three models of follow-up of patients treated for gynaecological cancer: attitudes in general practice and feasibility of randomisation. J Obstet Gynaecol 24: 165-166
22. Murchie P, Delaney EK, Campbell NC, Hannaford PC (2010) GP-led melanoma follow-up: views and feelings of patient participants. Support Care Cancer 18: 225-233
23. Murchie P, Hannaford PC, Wyke S, Nicolson MC, Campbell NC (2007) Designing an integrated follow-up programme for people treated for cutaneous malignant melanoma: a practical application of the MRC framework for the design and evaluation of complex interventions to improve health. Fam Pract 24: 283-292
24. Papagrigoriadis S, Heyman B (2001) The needs of general practitioners in the follow-up of patients with colorectal cancer. Eur J Surg Oncol 27: 541-544
25. Poo-Hwu WJ, Ariyan S, Lamb L, Papac R, Zelterman D, Hu GL, Brown J, Fischer D, Bolognia J, Buzaid AC (1999) Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma. Cancer 86: 2252-2258
26. Roberts DLL, Anstey AV, Barlow RJ, Cox NH, On behalf of the British Association of Dermatologists, Newton Bishop JA, Corrie PG, Evans J, Gore ME, Hall PN, Kirkham N, On behalf of the Melanoma Study Group (2002) UK guidelines for the management of cutaneous melanoma. Br J Dermatol 146: 7-17
27. Rozmovits L, Rose P, Ziebland S (2004) In the absence of evidence, who chooses? A qualitative study of patients' needs after treatment for colorectal cancer. J Health Serv Res Policy 9: 159-162
28. SIGN Guideline Number 72 (2003) Cutaneous Melanoma-A National Clinical Guideline. Scottish Intercollegiate Guideline Network: Edinburgh
29. Ware JE (1993) SF-36 Health Survey Manual and Interpretation Guide. Nimrod Press: Boston
30. Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, Platell C, Silagy C (2006) General practice vs surgical-based follow-up for patients with colon cancer: a randomised controlled trial. Br J Cancer 94: 1116-1121
31. Wright B, Linacre J (1992) Combining and splitting categories. Rasch Meas Trans 6: 233-235
32. Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67: 361-370